332 related articles for article (PubMed ID: 12345575)
1. OCs and genital tract malignancies.
Herbst AL
Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
[TBL] [Abstract][Full Text] [Related]
2. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
3. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
4. Expanded role for OCs. Question and answer.
Mishell Dr
Dialogues Contracept; 1994; 4(3):8. PubMed ID: 12345576
[TBL] [Abstract][Full Text] [Related]
5. Neoplastic effects of oral contraceptives.
Grimes DA
Int J Fertil; 1991; 36 Suppl 1():19-24. PubMed ID: 1678377
[TBL] [Abstract][Full Text] [Related]
6. [Possible link between long-term oral contraceptive use and cervical cancer].
Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
[TBL] [Abstract][Full Text] [Related]
7. [Cancers of the uterus and ovary and the contraceptive pill].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):339-43. PubMed ID: 12280204
[TBL] [Abstract][Full Text] [Related]
8. Time to end bias against the pill.
Potts M
Entre Nous Cph Den; 1992 May; (20):10-1. PubMed ID: 12222224
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives and cancer of the reproductive organs.
Huezo C
IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511
[TBL] [Abstract][Full Text] [Related]
10. The myth about contraceptives and breast cancer.
Ibekwe J
Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
[TBL] [Abstract][Full Text] [Related]
11. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
Le Coutour X
NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
[TBL] [Abstract][Full Text] [Related]
12. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
13. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
Grimes DA
Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and neoplasia.
Stubblefield PG
J Reprod Med; 1984 Jul; 29(7 Suppl):524-9. PubMed ID: 6481705
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
16. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
17. OCs protect against ovarian cancer: effect may last as long as 15 years.
Contracept Technol Update; 1987 Apr; 8(4):48-9. PubMed ID: 12342892
[TBL] [Abstract][Full Text] [Related]
18. Non-contraceptive benefits of oral contraceptives.
Prog Hum Reprod Res; 1996; (39):6-7. PubMed ID: 12292200
[TBL] [Abstract][Full Text] [Related]
19. [Oral contraceptives: recent safety studies (author's transl)].
Edgren RA
Contracept Fertil Sex (Paris); 1983 Sep; 11(9):975-83. PubMed ID: 12279633
[TBL] [Abstract][Full Text] [Related]
20. Contraception and the big "C".
Chandran R
Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
